Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
A group of Australian researchers has developed a statistical model that may help men to be able to make better choices about their need for prostate cancer screening. But not everyone is going to agree with this point of view! At the same time, an article in the BMJ by a team of Harvard epidemiologists [...]
Filed under: Diagnosis, Risk | Tagged: choice, PSA, screening, testing | 6 Comments »
A recent Phase II trial of the COX-2 inhibitor celecoxib (Celebrex/Pfizer) showed that this agent “had no effect on intermediate biomarkers of prostate carcinogenesis.”
Filed under: Drugs in development, Prevention | Tagged: celecoxib, COX-2, Prevention | Leave a Comment »
We have long cautioned about whether the presence of apparent biologic “markers” in men with prostate cancer (“association”) is necessarily an implication that a specific marker really indicates anything clinically important. A paper published by a European team now helps to put this in perspective.
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: association, fusion, gene, marker, TMPRSS2-ERG | 5 Comments »
A long-term study from the Mayo Clinic reports a low incidence of complications (other than erectile dysfunction) following salvage radiotherapy for men with prostate cancer recurrence after an initial radical prostatectomy.
Filed under: Management, Treatment | Tagged: EBRT, post-surgery, radiation, salvage | Leave a Comment »
A new study has clearly shown the value of the Prostate Cancer Prevention Trial (PCPT) risk calculator in the evaluation of risk for prostate cancer in a cohort of young, racially diverse, high-risk men with a low baseline PSA level.
Filed under: Diagnosis, Risk | Tagged: PCPT calculator, risk | 2 Comments »
In today’s news reports we cover items on: Risks for prostate cancer from smoking and increased adipose tissue The role of religious activities in prostate cancer testing among African Americans Blood loss at the time of surgery and risk for progressive disease
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: adipose, blood loss, BMI, body mass index, DRE, ethnicity, recurrence, religion, risk, smoking | Leave a Comment »
Search for new and
ongoing trials on the
CTAG PCa web site